Alexandra S Rashedi1, Saskia F de Roo1, Lauren M Ataman1, Maxwell E Edmonds1, Adelino Amaral Silva1, Anibal Scarella1, Anna Horbaczewska1, Antoinette Anazodo1, Ayse Arvas1, Bruno Ramalho de Carvalho1, Cassio Sartorio1, Catharina C M Beerendonk1, Cesar Diaz-Garcia1, Chang Suk Suh1, Cláudia Melo1, Claus Yding Andersen1, Eduardo Motta1, Ellen M Greenblatt1, Ellen Van Moer1, Elnaz Zand1, Fernando M Reis1, Flor Sánchez1, Guillermo Terrado1, Jhenifer K Rodrigues1, João Marcos de Meneses E Silva1, Johan Smitz1, Jose Medrano1, Jung Ryeol Lee1, Katharina Winkler-Crepaz1, Kristin Smith1, Lígia Helena Ferreira Melo E Silva1, Ludwig Wildt1, Mahmoud Salama1, María Del Mar Andrés1, Maria T Bourlon1, Mario Vega1, Maurício Barbour Chehin1, Michel De Vos1, Mohamed Khrouf1, Nao Suzuki1, Osama Azmy1, Paula Fontoura1, Paulo Henrique Almeida Campos-Junior1, Peter Mallmann1, Ricardo Azambuja1, Ricardo M Marinho1, Richard A Anderson1, Robert Jach1, Roberto de A Antunes1, Rod Mitchell1, Rouhollah Fathi1, Satish Kumar Adiga1, Seido Takae1, Seok Hyun Kim1, Sergio Romero1, Silvana Chedid Grieco1, Talya Shaulov1, Tatsuro Furui1, Teresa Almeida-Santos1, Willianne Nelen1, Yasmin Jayasinghe1, Yodo Sugishita1, Teresa K Woodruff1. 1. Alexandra S. Rashedi, Lauren M. Ataman, Maxwell E. Edmonds, Kristin Smith, and Teresa K. Woodruff, Northwestern University, Chicago, IL; Saskia F. de Roo, Catharina C.M. Beerendonk, and Willianne Nelen, Radboud University Medical Centre, Nijmegen, the Netherlands; Adelino Amaral Silva, GENESIS-Center for Assistance in Human Reproduction; Bruno Ramalho de Carvalho, BONVENA-Reproductive Medicine, Brasília; Eduardo Motta, Fernando M. Reis and Jhenifer K. Rodrigues, Universidade Federal de Minas Gerais; Ricardo M. Marinho, Pró-Criar Medicina Reprodutiva, Minas Gerais, Belo Horizonte; Silvana Chedid Grieco, IVI São Paulo-Chedid Grieco, São Paulo; João Marcos de Meneses e Silva and Lígia Helena Ferreira Melo e Silva, Ceará Blood Center, Fortaleza; Cassio Sartorio, Vida Centro de Fertilidade; Paula Fontoura, Banco de Sêmen do Rio de Janeiro; Roberto de A. Antunes, Fertipraxis Centro de Reprodução Humana, Rio de Janeiro; Paulo Henrique Almeida Campos-Junior, Federal University of São João del-Rei, São João del-Rei; Ricardo Azambuja, Fertilitat Centro de Medicina Reprodutiva, Porto Alegre, Brazil; Anibal Scarella, Universidad de Valparaiso, Valparaiso, Chile; Anna Horbaczewska and Robert Jach, Jagiellonian University Medical College, Kraków, Poland; Antoinette Anazodo, University of New South Wales, Sydney, New South Wales; Yasmin Jayasinghe, Royal Women's Hospital, Melbourne, Victoria, Australia; Ayse Arvas, Onkofertilite Turkiye, Istanbul, Turkey; Cesar Diaz-Garcia, University of Valencia; Jose Medrano and María del Mar Andrés, Instituto de Investigación Sanitaria La Fe, Valencia, Spain; Chang Suk Suh, Jung Ryeol Lee, and Seok Hyun Kim, Seoul National University Hospital College of Medicine; Seoul, South Korea; Cláudia Melo and Teresa Almeida-Santos, University of Coimbra, Coimbra, Portugal; Claus Yding Andersen, University of Copenhagen, Copenhagen, Denmark; Ellen M. Greenblatt, University of Toronto, Toronto, Ontario; Talya Shaulov, University of Montreal Hospital Centre, Montreal, Quebec, Canada; Ellen Van Moer and Johan Smitz, Universitair Ziekenhuis Brussel; Michel De Vos, Vrije Universiteit Brussel, Brussels, Belgium; Elnaz Zand and Rouhollah Fathi, Royan Institute for Reproductive Biomedicine, Tehran, Iran; Flor Sánchez and Sergio Romero, Centro de Estudios e Investigaciones en Biología y Medicina Reproductiva, Lima, Peru; Guillermo Terrado, Pregna Medicina Reproductiva, Caba, Argentina; Katharina Winkler-Crepaz and Ludwig Wildt, Medical University of Innsbruck, Innsbruck, Austria; Mahmoud Salama and Osama Azmy, National Research Center, Cairo, Egypt; Maria T. Bourlon, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico; Mario Vega, IVF Centro de Reproducción, Panama City, Panama; Maurício Barbour Chehin, University of Santo Amaro; Manila, Philippines; Mohamed Khrouf, Université de Tunis El Manar, Tunis, Tunisia; Nao Suzuki, Seido Takae, and Yodo Sugishita, St Marianna University School of Medicine, Kawasaki; Tatsuro Furui, Gifu University School of Medicine, Gifu, Japan; Peter Mallmann, University of Cologne, Cologne, Germany; Richard A. Anderson and Rod Mitchell, University of Edinburgh, Edinburgh, United Kingdom; and Satish Kumar Adiga, Manipal University, Manipal, India.
Abstract
PURPOSE: Oncofertility focuses on providing fertility and endocrine-sparing options to patients who undergo life-preserving but gonadotoxic cancer treatment. The resources needed to meet patient demand often are fragmented along disciplinary lines. We quantify assets and gaps in oncofertility care on a global scale. METHODS: Survey-based questionnaires were provided to 191 members of the Oncofertility Consortium Global Partners Network, a National Institutes of Health-funded organization. Responses were analyzed to measure trends and regional subtleties about patient oncofertility experiences and to analyze barriers to care at sites that provide oncofertility services. RESULTS: Sixty-three responses were received (response rate, 25%), and 40 were analyzed from oncofertility centers in 28 countries. Thirty of 40 survey results (75%) showed that formal referral processes and psychological care are provided to patients at the majority of sites. Fourteen of 23 respondents (61%) stated that some fertility preservation services are not offered because of cultural and legal barriers. The growth of oncofertility and its capacity to improve the lives of cancer survivors around the globe relies on concentrated efforts to increase awareness, promote collaboration, share best practices, and advocate for research funding. CONCLUSION: This survey reveals global and regional successes and challenges and provides insight into what is needed to advance the field and make the discussion of fertility preservation and endocrine health a standard component of the cancer treatment plan. As the field of oncofertility continues to develop around the globe, regular assessment of both international and regional barriers to quality care must continue to guide process improvements.
PURPOSE: Oncofertility focuses on providing fertility and endocrine-sparing options to patients who undergo life-preserving but gonadotoxic cancer treatment. The resources needed to meet patient demand often are fragmented along disciplinary lines. We quantify assets and gaps in oncofertility care on a global scale. METHODS: Survey-based questionnaires were provided to 191 members of the Oncofertility Consortium Global Partners Network, a National Institutes of Health-funded organization. Responses were analyzed to measure trends and regional subtleties about patient oncofertility experiences and to analyze barriers to care at sites that provide oncofertility services. RESULTS: Sixty-three responses were received (response rate, 25%), and 40 were analyzed from oncofertility centers in 28 countries. Thirty of 40 survey results (75%) showed that formal referral processes and psychological care are provided to patients at the majority of sites. Fourteen of 23 respondents (61%) stated that some fertility preservation services are not offered because of cultural and legal barriers. The growth of oncofertility and its capacity to improve the lives of cancer survivors around the globe relies on concentrated efforts to increase awareness, promote collaboration, share best practices, and advocate for research funding. CONCLUSION: This survey reveals global and regional successes and challenges and provides insight into what is needed to advance the field and make the discussion of fertility preservation and endocrine health a standard component of the cancer treatment plan. As the field of oncofertility continues to develop around the globe, regular assessment of both international and regional barriers to quality care must continue to guide process improvements.
Authors: Joseph M Letourneau; Erin E Ebbel; Patricia P Katz; Audra Katz; Wei Z Ai; A Jo Chien; Michelle E Melisko; Marcelle I Cedars; Mitchell P Rosen Journal: Cancer Date: 2011-09-01 Impact factor: 6.860
Authors: Stephanie J Lee; Leslie R Schover; Ann H Partridge; Pasquale Patrizio; W Hamish Wallace; Karen Hagerty; Lindsay N Beck; Lawrence V Brennan; Kutluk Oktay Journal: J Clin Oncol Date: 2006-05-01 Impact factor: 44.544
Authors: Alison W Loren; Pamela B Mangu; Lindsay Nohr Beck; Lawrence Brennan; Anthony J Magdalinski; Ann H Partridge; Gwendolyn Quinn; W Hamish Wallace; Kutluk Oktay Journal: J Clin Oncol Date: 2013-05-28 Impact factor: 44.544
Authors: Ceara Tess Cunningham; Hude Quan; Brenda Hemmelgarn; Tom Noseworthy; Cynthia A Beck; Elijah Dixon; Susan Samuel; William A Ghali; Lindsay L Sykes; Nathalie Jetté Journal: BMC Med Res Methodol Date: 2015-04-09 Impact factor: 4.615
Authors: Alexandra S Rashedi; Saskia F de Roo; Lauren M Ataman; Maxwell E Edmonds; Adelino Amaral Silva; Anibal Scarella; Anna Horbaczewska; Antoinette Anazodo; Ayse Arvas; Bruno Ramalho de Carvalho; Cassio Sartorio; Catharina C M Beerendonk; Cesar Diaz-Garcia; Chang Suk Suh; Cláudia Melo; Claus Yding Andersen; Eduardo Motta; Ellen M Greenblatt; Ellen Van Moer; Elnaz Zand; Fernando M Reis; Flor Sánchez; Guillermo Terrado; Jhenifer K Rodrigues; Joao Marcos de Meneses E Silva; Johan Smitz; Jose Medrano; Jung Ryeol Lee; Katharina Winkler-Crepaz; Kristin Smith; Lígia Helena Ferreira Melo E Silva; Ludwig Wildt; Mahmoud Salama; María Del Mar Andrés; Maria T Bourlon; Mario Vega; Maurício Barbour Chehin; Michel De Vos; Mohamed Khrouf; Nao Suzuki; Osama Azmy; Paula Fontoura; Paulo Henrique Almeida Campos-Junior; Peter Mallmann; Ricardo Azambuja; Ricardo M Marinho; Richard A Anderson; Robert Jach; Roberto de A Antunes; Rod Mitchell; Rouhollah Fathi; Satish Kumar Adiga; Seido Takae; Seok Hyun Kim; Sergio Romero; Silvana Chedid Grieco; Talya Shaulov; Tatsuro Furui; Teresa Almeida-Santos; Willianne Nelen; Yasmin Jayasinghe; Yodo Sugishita; Teresa K Woodruff Journal: J Glob Oncol Date: 2017-06-30